Trust results - National Oesophago-Gastric Cancer Audit

Time period: 2020-2022
	Organisation		National
Number of oesophago-gastric (OG) cancer patients in audit	331		19,865
Case ascertainment for OG cancer (%)	85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission Percent figure accounts for differences in mix of patients across organisations	83	25.0%	13.1%
– Patients with referral source reported as unknown	0	0.0%	1.4%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded	320	96.7%	94.0%
Treatment planning
– Patients having a plan for curative treatment	135	40.8%	37.2%
– Patients having a plan for non-curative treatment	196	59.2%	62.8%
– Patients with non-curative plans having chemotherapy or radiotherapy	77	39.3%	34.7%

Time period: 2019-2022
	Organisation	National
Number of patients having surgery	83	5452
Length of stay, median (days)	9	10
Operations in which 15 or more lymph nodes were examined (%)	67.1%	90.1%
30-day postoperative mortality (%)	2.0%	1.5%
90-day postoperative mortality (%)	4.2%	2.9%
Oesophageal surgery
Number of patients having oesophageal surgery	57	N/A
Oesophageal patients with positive longitudinal margins (%)	0.0%	4.9%
Oesophageal patients with positive circumferential margins (%)	17.4%	21.5%
Gastric surgery
Number of patients having gastric surgery	26	N/A
Gastric patients with positive longitudinal margins (%)	3.6%	9.8%

Betsi Cadwaladr University Health Board